ResMed (RMD) reported $1.29 billion in revenue for the quarter ended March 2025, representing a year-over- year increase of 7.9$2.37 for the same period compares to $2.13 a year ago. The reported revenue compares to the Zacks Consensus Estimate of$1.28 billion, representing a surprise of +0.53%. The company delivered an EPS surprise of +0.42%, with the consensus EPS estimate being $2.36. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...